Appareil pulmonaire
AMGEN_20210004 (AMG 757)
A Randomized, Open-label, Phase 3 Study of;Tarlatamab Compared With Standard of Care in;Subjects With Relapsed Small Cell Lung Cancer;After Platinum-based First-line Chemotherapy;(DeLLphi-304)
Paris
NICOLAS GIRARD